Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis
NCT ID: NCT05784948
Last Updated: 2023-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
67 participants
INTERVENTIONAL
2020-04-08
2021-06-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of a Virtual Reality Intervention on Stigma, Empathy and Attitudes Towards People With Psychotic Disorders
NCT05982548
Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis
NCT06870305
Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis
NCT07091344
Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques
NCT05830903
The Effectiveness of Combining AR/VR Technology in Virtual Clinical Auditory Hallucinations on the Comprehensive Auditory Hallucination Nursing Competency of Psychiatric Nurses
NCT06938997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual Reality Mindfulness Treatment
Experience virtual reality mindfulness treatment with a screen from a head-mounted display for 30 minutes in a comfortable sitting position.
Virtual Reality Mindfulness Treatment
once a week for 30 minutes, over 8 weeks
Relaxing scenery and music experience
Experience relaxing scenery and music with a screen from a head-mounted display for 30 minutes in a comfortable sitting position.
Experience relaxing scenery and music
once a week for 30 minutes, over 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality Mindfulness Treatment
once a week for 30 minutes, over 8 weeks
Experience relaxing scenery and music
once a week for 30 minutes, over 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with current DSM-5 (Diagnostic and Statistical Manual of Mental Disorders-fifth edition) diagnosis schizophrenia spectrum and other psychotic disorders including bipolar and related disorders or depressive disorder with psychotic symptoms.
* Patients who can agree to participate in the study in a stable state (Clinical Global Impression score of 5 or less) and cooperate appropriately with questionnaires and tests.
* Patients with a SOFAS score in the range of 41 to 80 points.
* Patients with a PANSS score of less than 85 points.
Exclusion Criteria
* Patients who are currently pregnant or lactating.
* Patients who are accompanying intellectual disability with an Intelligence Quotient (IQ) of 70 or lower
* Patients who have difficulty in agreeing to and participating in research due to severely impaired ability to verify reality
* Patients with a PANSS score of 85 or higher or a CGI of 6 or higher
* Patients with a SOFAS score of 40 or less or 81 or more
* Patients who are currently in hospitalized
15 Years
59 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chonbuk National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Young Chul Chung
Professor of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Young-chul Chung, MD
Role: PRINCIPAL_INVESTIGATOR
Chonbuk National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry, Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-01-042
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.